This lecture is presented by our volunteer Zargul sadein, she is from Karachi, Pakistan, and she is covering "Developing Therapeutic Approaches For Emerging Viral Diseases."
for video: https://www.youtube.com/watch?v=DcI89jpjbxc
The twenty-first century has already recorded more than
ten major epidemic or pandemic virus emergence events,
including the ongoing and devastating coronavirus disease
2019 (COVID-19) pandemic. As viral disease emergence is
expected to accelerate, there is a need for proactive
approaches to develop broadly active family-specific and
cross-family therapeutics for use in future disease
7. Antiviral drugs target
specific components of
the viral lifecycle,
inhibiting their replication
and spread within the
Vaccines stimulate the
immune system to
recognize and mount a
defense against the virus
without causing disease.
e.g. Pfizer-BioNTech and
harness the body's
immune response to fight
The COVID-19 pandemic serves as a stark
reminder of the importance of developing
diverse therapeutic approaches to emerging
COVID-19 response provide a blueprint for
addressing future viral threats, emphasizing
the need for swift action, international
collaboration, and the continuous advancement
of therapeutic strategies to safeguard global
health and well-being.
1. Meganck, R.M., Baric, R.S. Developing therapeutic approaches for twenty-
first-century emerging infectious viral diseases. Nat Med 27, 401–410 (2021).
2. Jones, K. E., Patel, N. G., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J.
L., & Daszak, P. (2008). Global trends in emerging infectious diseases.
Nature, 451(7181), 990-993.
3. Fauci, A. S., & Morens, D. M. (2012). The perpetual challenge of infectious
diseases. New England Journal of Medicine, 366(5), 454-461.